Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 10 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 10 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Our Mission
Our mission is to restore cell health and resilience through cell rejuvenation to reverse disease, injury, and the disabilities that can occur throughout life.
For more information, see our website at altoslabs.com.
Our Value
Our Single Altos Value: Everyone Owns Achieving Our Inspiring Mission .
Diversity at Altos
Altos Labs has been named one of the Top 3 Biotech Companies and ranked for the second year on the Forbes 2026 Best Startups in America list. At Altos, exceptional scientists and industry leaders from around the world work together to advance a shared mission. Our intentional focus is on Belonging, so that all employees know that they are valued for their unique perspectives. We are all accountable for sustaining a diverse and inclusive environment.
What You Will Contribute To Altos
An exciting opportunity is available for a talented Director / Senior Director of Toxicology to join the Drug Discovery and Development Sciences team at Altos Labs.
We are seeking a highly motivated, creative, and collaborative scientist who is passionate about applying scientific expertise to restore cell health and resilience and reverse disease.
This position will play an important role in advancing novel therapeutic programs within a multidisciplinary environment, working closely with the discovery organization and cross-functional teams across Altos. The role will support discovery and development programs spanning multiple therapeutic areas and modalities, with a strong emphasis on early safety assessment, investigative toxicology, and translational science.
The successful candidate will bring deep scientific expertise in toxicology, experience with traditional and emerging therapeutic modalities, and a demonstrated ability to develop and execute innovative toxicology strategies within the biotechnology or pharmaceutical industry.
Responsibilities:
Toxicology Strategy and Scientific Expertise
• Develop and implement toxicology strategies to support discovery and development programs, leveraging internal capabilities and external contract research organizations (CROs).
• Conduct target safety assessments and collaborate closely with scientists in the discovery organization to identify, characterize, and mitigate potential safety risks associated with novel therapeutic targets.
• Design and execute in vitro and in vivo safety assessments to support lead optimization of small molecules, antisense oligonucleotides (ASOs), gene therapy, and other therapeutic modalities.
• Apply investigative and mechanistic toxicology approaches to understand potential safety liabilities and inform program decisions.
• Integrate toxicology findings with pharmacology, DMPK, and other relevant data to support target validation, lead optimization, and therapeutic candidate selection.
• Identify and apply innovative scientific approaches and technologies to address emerging toxicology challenges.
Program Execution and Cross-Functional Collaboration
• Plan, coordinate, and oversee toxicology studies conducted internally and through external CROs, ensuring scientific rigor, data quality, and timely delivery.
• Represent Toxicology on multidisciplinary discovery and early development project teams, providing scientific expertise and recommendations to support program advancement.
• Collaborate closely with the discovery organization, In Vitro and In Vivo Pharmacology, Discovery Chemistry, DMPK, Pathology, Nonclinical Operations, and other functional groups to integrate safety considerations into research and development activities.
• Establish effective working relationships with internal and external scientific partners to support toxicology activities across programs and Altos sites.
• Contribute to the development and contin
Apply on employer site ↗